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Background: Women with hirsutism have reported imparied health and health-related quality of life (HRQoL). Social
support is a factor that might increase HRQoL in chronic diseases, but little is known about this association among
women with hirsutism.
Aim: The aim of the study was to describe social support and explore its association with HRQoL among women with
hirsutism. A further aim was to compare HRQoL in women with hirsutism with a Swedish normal population.
Methods: A questionnaire including socio-demographic questions, Short-Form Health Survey (SF-36), the
Multidimensional Scale of Perceived Social Support (MSPSS), and a self-estimation of hairiness using the
Ferriman-Gallway scale (F-G scale) was answered by 127 women with hirsutism.
Results: Multiple regression analyses showed significant associations between social support and all health
dimensions in the SF-36, also after the model was adjusted for age, hairiness and body mass index. Compared
to the normal Swedish population, women with hirsutism reported significantly lower HRQoL in all dimensions
of the SF-36 (p < 0.01).
Conclusions: There is a significant positive association between social support and HRQoL, demonstrating its
importance for the ability to adapt to problems associated with hirsutism. As women with hirsutism reported
poorer HRQoL compared to the normal population, social support may be a factor to consider in clinical practice.
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It is known that chronic skin diseases can be accompanied
by psychological and social disabilities [1-3]. One such dis-
ease is hirsutism, which means a woman having excessive
terminal hair in a male pattern distribution. It is caused
by elevated androgen exposure to the hair follicles [4-6],
mostly because of polycystic ovary syndrome (PCOS) [7],
or by an increased sensitivity to normal levels of circu-
lating androgens, i.e., idiopathic hirsutism. Hirsutism has
been reported to have a negative effect on health-related
quality of life (HRQoL) [8-11], and anxiety and depression
is more common than among women without hirsutism
[12]. In women with PCOS, changes due to PCOS might* Correspondence: maria.palmetun-ekback@orebroll.se
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unless otherwise stated.contribute to psychological morbidity [10,13-19] and a
feeling of being stigmatized [20].
Adaptation to living with a chronic disease encompasses
a range of phenomena, e.g., HRQoL, emotional well-
being, acceptance of a life with a chronic disease and
finding a way of participating in society [21]. Social sup-
port could be one contributor to the adaption to a life with
a chronic disease and a factor that affects the outcome of
HRQoL. Furthermore, it is known to influence outcomes
such as anxiety and depression in a variety of chronic
diseases [22-24]. Social support is commonly used as a
general concept that includes some kind of relationship
transactions between individuals. Perceived social support
seems to be most important [25] and can be emotional,
instrumental (practical), informative, or appraisal [26].
It could be that the quality of the social support among
women with hirsutism determines how well they can
cope with their situation and adapt in social situations.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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skin diseases has only been studied to a minor extent
[21,27], and to our knowledge, not at all in women with
hirsutism. The aim of the present study was therefore to
describe social support and explore its association with
HRQoL among women with hirsutism. A further aim was
to compare HRQoL in women with hirsutism with a
Swedish normal population.Methods
Sample
Women who, according to their medical records, were di-
agnosed with hirsutism at the departments of dermatology
in Malmö (n = 100) and Örebro (n = 80), or had on-going
treatment for hirsutism (n = 20) at a private dermato-
logical clinic in Uppsala were invited to participate in
the study. A questionnaire was sent with one reminder
to the 200 identified women, of whom 132 responded
(66%). Five women were excluded because of wrong diag-
nosis (which was found in the questionnaire), psychiatric
illness or failure to complete the questionnaires. The study
sample finally consisted of 127 women. It was possible to
identify 55 of the non-respondents. Reasons given for not
participating were: difficult language in the questionnaire
(n = 11), forgotten to answer (n = 11), too private ques-
tions (n = 15), did not have time to fill in the question-
naire (n = 5), no problems anymore (n = 4), do not want
to answer (n = 1), and no reason given (n = 8).
A Swedish normal sample was recruited from a nation-
wide survey based on a questionnaire on subjectively per-
ceived health, quality of life (SF-36), and use of medication
[28]. Sweden keeps a population register based on the
unique personal number held by all people who are legal
residents in the country. The questionnaire was sent by
mail to a random sample from this register, i.e., a random
sample of the Swedish population (n = 7985), aged 18–84
years. The survey was performed between October 2004
and January 2005. We obtained the SF-36 data for an age-
adjusted sample of 1 115 women from this survey.
The study was conducted between October 2010 and
August 2012. It was approved by the Regional Ethics
Committee in Uppsala (study code: 2010/207).Data collection and measures
Data were collected by a self-rated questionnaire, composed
of 4 parts; i) socio-demographic questions (age, employ-
ment, education, civil status, children, body mass index
(BMI), income, satisfaction with work, social contact), ii)
self-estimation of hairiness (the Ferriman-Gallwey scale,
F-G scale), iii) HRQoL (the 36 Short- Form Health Survey,
SF-36) and iv) perceived social support (the Multidimen-
sional Scale of Perceived Social Support, MSPSS).The Ferriman-Gallwey scale
The modified Ferriman-Gallwey scale (F-G scale) is a vis-
ual self-rating method to determine hairiness in nine
androgen dependent body areas [29,30]. The scale ranges
from 0 to 36, and the cut-off score for hirsutism is a value
over six, except in facial areas where a F-G score ≥ 2 also
is considered as hirsutism [31,32].
The 36 short-form health survey
The 36 Short- Form Health Survey (SF-36) is a generic
HRQoL instrument. It contains 36 items and eight health
domains: physical functioning (PF, limitation in perform-
ing physical activities such as bathing or dressing), role-
physical (RP, limitation in work and other daily activities),
bodily pain (BP, bodily pain), general health (GH, how the
person perceives her/his own general health), vitality (VT,
a feeling of being tired, worn out vs. feeling energetic),
social functioning (SF, interference with normal social
activities due to physical or emotional problems), role
emotional (RE, limitations in daily activities or work due
to emotional problems), and mental health (MH, feeling
happy or calm vs. nervous and depressed). Scores for each
health domain range from 0 to 100. The higher the score,
the better the health in that domain. The questionnaire
has two main components, one physical (PCS) and one
mental (MSC), also with a possible score range between
0 and 100.
The multidimensional scale of perceived social support
The Multidimensional Scale of Perceived Social Support
(MSPSS) was constructed by Zimet et al. [25] and aims
to assess perceived social support. It includes 12 items
which cover three dimensions: family, friends and signifi-
cant others. Each item is rated on a seven-point Likert-
type scale (1 = very strongly disagree; 7 = very strongly
agree). A total score is calculated by summing the re-
sults for all items. Scores range between 12 and 84, where
higher scores indicate higher perceived social support. In
addition, separate subscales can be used by summing the
responses from the items in each of the three dimensions.
The possible score range for the subscales is 4 to 28
respectively. The instrument has been found to be reli-
able and valid, both in its original language [33] and in
other languages [34,35]. In the present study, a Swedish
validated version of the MSPSS was used [36].
Statistical analysis
Descriptive statistics were used to describe patient demo-
graphics, clinic characteristics, perceived social support,
and HRQoL.
The association between social support and HRQoL was
explored by multiple linear regression analyses [37]. In a
first step (the initial model), HRQoL were entered as the
outcome variable, while social support was entered as the
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age, self-reported hairiness, and BMI were added as adjust-
ing covariates. As the subscales of social support were
highly correlated with one another (i.e. Family, Friends and
Significant others), the MSPSS total score was used to
avoid problems with multicolinearity.
Independent sample t-test was used to compare the
SF-36 dimensions between the study sample and the
normal population sample [38]. Cohen’s d effect size was
used to estimate the clinical importance of the difference
between the two groups [39]. The interpretation of Cohen’s
d effect size was as following: small (0.2), medium (0.5), or
large (0.8) [40].
The level of statistical significance was set at p < 0.05.
All analyses were conducted using SPSS version 21 for
Windows (IBM Corp, Armonk, NY, USA).
Results
Charateristics of the participants
The characteristics of the women with hirsutism and the
Swedish normal population sample are given in Table 1.
The mean age of women with hirsutism was 32.0 years.
Among the respondents, 44.9% lived with a partner, 48.8%




sample, n = 1115
Age, mean years (SD) 32.0 (10.2) 32.7 (7.9)
Gainfully employed, n (%)
Full time 55 (43.3)
Part time 15 (11.8)
Not working 35 (27.6)
Unknown 22 (17.3)
Civil status, n (%)
Living with a partner 57 (44.9)
Living alone 65 (51.2)
Unknown 5 (3.9)







BMI, mean (SD) [range] 28.2 (6.4) [17.8 - 47.7]





Significant other 22.7 (6.7)
BMI = Body Mass Index, F-G = Ferriman Gallwey score, MSPSS = Multidimensional
Scale of Perceived Social Support.working. Half of the women (53%) were satisfied with the
contact they had with family, friends, and colleagues, while
the others wanted more contact.
The normal population sample consisted of 1 115 women
with a mean age of 32.7 years. There were no significant
age differences between the women with hirsutism and the
normal population sample (p = 0.416).
Social support and the association with HRQoL
According to the distribution of MSPSS scores, women
with hirsutism reported generally high levels of perceived
social support, but with great individual variations
(Table 1). Perceived social support measured with MSPSS
revealed a mean score of 62.5. Of the three subscales, the
highest mean score was found in the subscale Significant
others (mean = 22.7). A mean score of 21.2 was reported
for the Family subscale, while the Friends subscale had the
lowest mean score (mean = 18.5). Scores lower than 15
were reported by 33% of the women on the Friends sub-
scale, by 19% on the Family subscale, and by 13% on the
Significant others subscale.
The multiple linear regression analysis revealed a sig-
nificant association between perceived social support and
HRQoL (Table 2). In the initial model, social support
(MSPSS total score) was significantly associated with all
health domains in the SF-36, as well as the MCS. Social
support explained 6% to 34% of the total variance in the
health domains in the SF-36 and 30% of the total vari-
ance in the MCS. However, social support explained a
larger share of the total variance in the mental domains
(Vitality, Social Functioning, Role Emotional and Mental
Health, R2 = 0.13-0.34), compared to the physical domains
(Physical Functioning, Role Physical, Bodily Pain and
General Health, R2 = 0.06-0.12). The association between
social support and HRQoL also remained after includ-
ing the adjusting covariates in the full model. The full
model, including all independent variables explained 14%
(Vitality) to 37% (Mental Health and MCS) of the total
variance in the different health domains and component
summary scores.
Among the covariates, hairiness was significantly asso-
ciated with bodily pain, social functioning, mental health,
and MCS. Age and BMI were both associated with phys-
ical functioning bodily pain and PCS. In addition, age was
also associated with MCS, while BMI was associated with
general health.
HRQoL comparison
Women with hirsutism and the normal population sample
both reported greatest health in Physical Functioning, 82.6
and 92.3 respectively. Both women with hirsutism and the
normal population sample reported poorest health in Vi-
tality, 41.2 and 54.5 respectively. Women with hirsutism
reported significantly lower HRQoL than women in the
Table 2 Associations between social support and health-related quality of life
Initial model Full model
Dependent variable Independent variables β (SE) 95% CI for β β (SE) 95% CI for β
Physical Functioning MSPSS 0.36 (0.10)*** 0.15/0.56 0.26 (0.10)** 0.07/0.45
n = 123 Age −0.72 (0.18)*** −1.07 / -0.38
F-G score −0.35 (0,21) −0.77/0.07
BMI −0.81 (0.27)** −1.34/-0.28
Model statistics: F(1, 121) = 12.10, p < 0.001, R2 = 0.09 F(4, 120) = 11.31, p < 0.001, R2 = 0.29
Role-Physical MSPSS 0.70 (0.17)*** 0.40/1.08 0.63 (0.18)*** 0.28/0.98
n = 123 Age −0.47 (0.32) −1.12/0.17
F-G score −0.55 (0.40) −1.34/0.24
BMI −0.70 (0.51) - 1.71/0.32
Model statistics F(1, 121) = 18.50, p < 0.001, R2 = 0.13 F(4, 118) = 6.26, p < 0.001, R2 = 0.18
Bodily Pain MSPSS 0.43 (0.14)** 0.14/0.71 0.28 (0.14)* 0.02/0.56
n = 125 Age −15.47 (5.15)*** −1.37/-0.36
F-G score −0.61 (0.30)* −1.33/-0.11
BMI - 0.97 (0.39)* −1.66/-0.11
Modell statistics F(1, 123) = 8.85, p = 0.004, R2 = 0.06 F(4, 120) = 8.43, p < 0.001, R2 = 0.19
General Health MSPSS 0.46 (0.11)*** 0.24/0.68 0.38 (0.11)*** 0.16/0.60
n = 125 Age −0.13 (0.21) −0.54/0.27
F-G score −0.17 (0.25) −0.66/0.32
BMI −1.22 (0.32)*** −1.84/-0.59
Model statistics F(1, 123) = 16.54, p < 0.001,R2 = 0.12 F(4, 120) = 9.09, p < 0.001, R2 = 0.23
Vitality MSPSS 0.46 (0.11)*** 0.26/0.67 0.41 (0.11)*** 0.20/0.63
n = 125 Age 0.08 (0.20) −0.31/0.48
F-G score −0.35 (0.24) −0.82/0.13
BMI −0.37 (0.31) −0.97/0.24
Model statistics F(1, 123) = 19.48, p < 0.001, R2 = 0.13 F(4, 120) = 6.01, p < 0.001,R2 = 0.14
Social Functioning MSPSS 0.84 (0.14)*** 0.55/1.12 0.70 (0.14)*** 0.42/0.98
n = 125 Age 0.13 (0.26) −0.38/0.64
F-G score −1.24 (0.31)*** −1.86/-0.62
BMI −0.32 (0.40) - 1.11/0.47
Model statistics F(1, 123) = 33.48, p < 0.001, R2 = 0.21 F(4, 120) = 14.56, p < 0.001, R2 = 0.33
Role-Emotional MSPSS 1.15 (0.19)*** 0.77/1.53 1.07 (0.20)*** 0.67/1.47
n = 122 Age 0.04 (0.36) −0.68/0.76
F-G score −0.56 (0.45) −1.44/0.33
BMI −0.43 (0.58) −1.57/0.71
Model statistics F(1, 120) = 35.77, p < 0.001, R2 = 0.23 F(4, 117) = 9.50, p < 0.001, R2 = 0.25
Mental Health MSPSS 0.79 (0.10)*** 0.59/0.98 0.74 (0.10)*** 0.54/0.94
n = 125 Age 0.21 (0.18) −0.15/0.57
F-G score −0.48 (0.22)* −0.92/-0.04
BMI −0.09 (0.28) −0.65/0.47
Model statistics F(1, 123) = 64.79, p < 0.001, R2 = 0.34 F(4,120) = 19.14, p < 0.001, R2 = 0.37
PCS MSPSS 0.10 (0.06) −0.06/0.21 0.05 (0.05) −0.05/0.15
n = 122 Age −0.37 (0.09)*** −0.55/-0.19
F-G score −0.16 (0.11) −0.38/0.07
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Table 2 Associations between social support and health-related quality of life (Continued)
BMI −0.48 (0.15)*** −0.77/-0.19
Model statistics F(1, 120) = 3.51, p = 0.064, R2 = 0.03 F(4, 117) = 9.84, p < 0.001,
R2 = 0.34
MCS MSPSS 0.44 (0.06)*** 0.41 (0.06)*** 0.29/0.54
n = 122 Age 0.23 (0.11)* 0.01/0.45
F-G score −0.33 (0.14)* −0.61/-0.05
BMI −0.05 (0.18) −0.40/0.31
Model statistics F(1, 120) = 49.91, p < 0.001, R2 = 0.30 F(4, 117) = 17.36, p < 0.001, R2 = 0.37
*p < 0.05; **p < 0.01; ***p < 0.001.
MSPSS =Multidimensional Scale of Perceived Social Support, PCS = Physical Component Summary, MCS =Mental Component Summary, BMI = Body Mass Index.
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as PCS and MCS (Table 3 & Figure 1). The effect size was
medium or large for all health domains, except Role Phys-
ical (d = 0.42), Bodily Pain (d = 0.24), and PCS (d = 0.31).
The largest effect size between the two groups was shown
for Social Functioning (d = 0.75), Role Emotional (d = 0.72),
and MCS (d = 0.79). With the exception of General Health
(d = 0.61), the largest effect size was demonstrated for the
emotional domains and MCS (Table 3).
A within group analysis comparing PCS with MCS
showed that both women with hirsutism and the normal
population sample reported significantly poorer mental
health compared to physical health, t(122) = 9.50, p < 0.001
and t(1104) = 17.57, p < 0.001 respectively. However, the
effect size was smaller in the normal population sample
compared with women with hirsutism, d = 0.75 and
d =1.21 respectively.
Discussion
To the best of our knowledge, this is the first study to
explorethe association between social support and HRQoL
in women with hirsutism. The main findings show that
social support is significantly associated with HRQoL, and
shown to be most prominent with mental health, but alsoTable 3 Health-related quality of life comparisons between w
SF-36 subscales Hirsutism mean (SD) n Nor
Physical Functioning 82.6 (21.5) 126 92.3
Role-Physical 66.5 (36.8) 124 81.1
Bodily Pain 67.4 (29.8) 126 74.1
General Health 58.2 (24.2) 126 72.5
Vitality 41.2 (22.7) 126 54.5
Social Functioning 60.7 (32.8) 126 82.1
Role-Emotional 50.1 (43.4) 123 78.6
Mental Health 56.0 (24.2) 126 71.3
PCS 48.7 (11.0) 123 51.8
MCS 32.9 (14.8) 123 43.7
aIndependent sample t-test.
bCohen’s d effect size: 0.2 = small, 0.5 = medium, 0.8 = large.associated with physical health. In the present study, we
also demonstrate that HRQoL was significantly lower in all
measured health domains in women with hirsutism com-
pared to a normal population of Swedish women.
The significant association between social support and
HRQoL indicates that the importance of family and friends
as supporters cannot be underestimated in the care of
women with hirsutism. Our findings are congruent with a
qualitative study by our research group, where the women
emphasised the importance of support from their family
members and friends [9]. Picardi et al. [27] found that in
psoriasis exacerbations, lack of social support affected not
only the HRQoL outcome, but may also precede a psoriasis
flare- up. A study of patients with breast cancer indicated
that hopelessness among the patients, measured with Beck
Hopelessness Scale (BH), was decreased when their social
support increased [41].
The level of perceived social support measured with
MSPSS in the present study was at similar levels to what
has been found in patients with diffuse plaque psoriasis
[27], but lower than in a Swedish group of nursing
students dominated by younger women whithout visible
skin diseases [36]. The reason for this could be that the
women with hirsutism, having visible hair on their faces,omen with hirsutism and the Swedish normal population
mal population mean (SD) n p-valuea ESb
(14.3) 1113 <0.001 0.53
(32.7) 1115 <0.001 0.42
(25.8) 1113 0.006 0.24
(22.4) 1105 <0.001 0.61
(23.1) 1113 <0.001 0.58
(23.4) 1114 <0.001 0.75
(35.1) 1111 <0.001 0.72
(20.1) 1111 <0.001 0.69
(9.0) 1105 <0.001 0.31
(12.4) 1105 <0.001 0.79
Figure 1 Health-related quality of life comparisons between women with hirutism and the Swedish normal population. PF = Physical
Functioning, RP = Role Physical, BP = Bodily Pain, GH = General Health, VT = vitality, SF = Social Functioning, RE = Role Emotional, MH = Mental
Health, PCS = Physical Component Summary, MCS = Mental Component Summary.
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with visible psoriasis do [42], and therefore withdraw from
social life.
In accordance with the findings in the present study, it
has previously been reported that hirsutism has a negative
effect on HRQoL [9]. Even if there are several options to
reduce hair in women with hirsutism, restoring a body to
normal hair growth is not possible. It is therefore im-
portant to identify and establish other factors, e.g., social
support, that can be part of the treatment and care for
these women. There are different types of social support,
one being informative support [26]. Informative support
is, for instance, provision of disease or health- relevant
information to the patient and should be provided by
healthcare personnel. It has been shown that in psoriasis,
social support is generally more effective for preventing
depression in women than in men [21]. It has also been
shown that given a symptom, a diagnosis and information
about that diagnosis brings relief to the patient [43]. It is
therefore important that when seeking healthcare, women
with hirsutism receive information and support [44].
From a socio-economic point of view, 55% of the women
with hirsutism were gainfully employed, which is a lower
proportion compared to the figure reported for the general
female population in Sweden [45]. As for HRQoL, theresults of this study demonstrate that all dimensions
in the SF-36 were significantly lower compared to a
Swedish normal population sample, but in accordance
with patients with severe dermatological states, such
as severe psoriasis [46], severe hand eczema [28] and
ichtyosis [47]. The dimensions with the most impaired
health were Vitality, Social Functioning, Role Emotional
and Mental Health. The mean score for Vitality among
hirsute women was even lower than reported in patients
with myasthenia gravis and multiple sclerosis [48]. The
dimensions with the greatest difference, according to
the Cohen’s d effect size between the group of women
with hirsutism and the normal population sample, was
Social Functioning and Role Emotional, which further
points to the fact that the women with hirsutism feel
stigmatized [20].
Methodological considerations
We have applied well established and validated techniques
to obtain self-reported data from women with hirsutism.
The use of the generic instrument SF-36 allows com-
parisons between different disease groups and general
populations [49,50]. One limitation is that SF-36 is not
specifically developed for measuring health in patients
with skin problems. Dermatology- specific instruments,
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as such allow comparisons between different skin diseases,
but could not be used for comparison with other non-
dermatological diseases. However, the SF-36 has been
widely used with different objectives in patients with
dermatology diseases. It has also been used as a reference
tool for HRQoL in validation studies of a dermatology-
specific instrument [51]. It has been compared with the
Dermatology Life Quality Index (DLQI), by using factor
analysis and found to be a useful instrument in measuring
HRQoL in patients with hand eczema [1].
One limitation is that the patients may have been mis-
diagnosed as they were recruited from medical records.
However, by using the F-G scale to define hairiness and
hirsutism, the possible negative effects were reduced. An-
other limitation could be that we have recruited patients
from three different centres, including one private clinic.
However, all women included in the study were diagnosed
with hirsutism by dermatologists, and the F-G scale was
used to define hirsutism and location of hairiness. A
further limitation is that this study had a cross-sectional
design, which reduces the possibility to draw any causal
conclusions about the relationship between social support
and HRQoL. Longitudinal studies of social support and
HRQoL are therefore needed.
No a priori sample size calculation was conducted, but
according to most rules of thumb [52], the sample size
can be deemed to be sufficiently large for a regression
model including four independent varaibles. In addition,
a post hoc power calculation showed that the statistical
power (1- β) in the present study varied between 0.55
and 0.87 for the regression models. Despite a somewhat
low power for some of the models, the association be-
tween social support and HRQoL was confirmed.
Conclusions
In the present study, we have confirmed that hirsutism
has a pronounced negative effect on women’s HRQoL,
particularly their mental health. Interventions to improve
HRQoL among women with hirustism therefore seem to
be of importance. We found a significant association be-
tween perceived social support and HRQoL, indicating
that improved social support is an important factor for en-
hancing HRQoL in hirsutism, particularly mental health
but also physical health. In order to improve HRQoL,
social support in clinical practice therefore seems to be a
factor to consider.
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